The impact and enlightenment of market-driven price comparison mechanisms on the prices of commonly used retail drugs
10.3969/j.issn.1674-2982.2025.10.002
- VernacularTitle:市场主导价格比较机制对医保常用零售药品价格的影响及启示
- Author:
Hong-yuan WU
1
;
Rong JIANG
;
Fan YANG
Author Information
1. 南京医科大学医政学院 江苏 南京 211166;清华大学医院管理研究院 广东 深圳 518055
- Publication Type:Journal Article
- Keywords:
Price index;
Retail drugs;
Public price comparison
- From:
Chinese Journal of Health Policy
2025;18(10):9-18
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the impact of public price comparison of medical insurance drugs on the prices of commonly used retail drugs,and to provide empirical analysis and theoretical basis for optimizing the price governance of commonly used retail drugs.Methods:Based on the sales and settlement data of commonly used drugs in medical insurance designated retail pharmacies in Shenzhen,Guangdong Province from December 2023 to February 2025,the chain Fisher index and ARIMA model were used to analyze the price change trend of commonly used retail drugs.Results:During the study period,the price level of commonly used drugs decreased significantly twice.However,during the stable period after the decline and in the prediction of the price level,the price level would rebound at an average monthly rate of 1%.The price changes of different categories of drugs showed significant heterogeneity:drugs with fierce market competition and higher common use were more affected by public price comparison,with larger price drops.The market-led price comparison mechanism has a weaker impact on drug price reduction than centralized volume-based procurement.Suggestions:Optimize the design and publicity of price comparison mini-programs to give full play to the due price control effect of social supervision,use medical insurance settlement data to build a drug price early warning mechanism,and guide enterprises to obtain profits by replacing price competition with technological innovation and service upgrading.
